These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15368523)

  • 1. Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors.
    Tamarit A; Alberola J; Mira JV; Tornero C; Galindo MJ; Navarro D
    J Med Virol; 2004 Nov; 74(3):382-9. PubMed ID: 15368523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
    J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.
    Lilleri D; Piccinini G; Genini E; Comolli G; Chiesa A; Tordato F; Sotgiu G; Parisi A; Baldanti F; Revello MG; Gerna G
    J Clin Virol; 2004 Apr; 29(4):297-307. PubMed ID: 15018859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A; Wohl DA; Barrett RJ; van der Horst C
    J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells.
    Lilleri D; Chiesa A; Fornara C; Maserati R; Lozza L; Comolli G; Gerna G
    Clin Microbiol Infect; 2007 Jan; 13(1):19-24. PubMed ID: 17184283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients.
    Piccinini G; Comolli G; Genini E; Lilleri D; Gulminetti R; Maccario R; Revello MG; Gerna G
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1225-30. PubMed ID: 11687467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
    Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.
    Gerna G; Piccinini G; Genini E; Percivalle E; Zavattoni M; Lilleri D; Testa L; Comolli G; Maserati R; Baldanti F; Maccario R; Monforte AD; Revello MG
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):320-31. PubMed ID: 11707667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.
    Blankson JN; Gallant JE; Siliciano RF
    J Infect Dis; 2001 Feb; 183(4):657-61. PubMed ID: 11170994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.
    Lilleri D; Fornara C; Furione M; Zavattoni M; Revello MG; Gerna G
    J Infect Dis; 2007 Apr; 195(7):1062-70. PubMed ID: 17330798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.